Multiple myeloma (MM) is a clonal proliferation of plasma cells invading the bone marrow and secreting monoclonal immunoglobulin. In order to study the epidemiological and biological and biochemical characteristics of MM, we carried out a retrospective work on a cohort of 50 cases collected at the Avicenna Military Hospital in Marrakesh, during a period of 5 years (from January 2013 to December 2017). Our study included 32 men (64%) and 18 women (36%), with an average age of 60.6 years, with extremes at 44 and 87 years. The circumstances of discovery were dominated by bone pain and alteration in general condition, which are revealing in more than 65% of cases. Biologically: the sedimentation rate was accelerated in 86% of cases, a monoclona...
OBJECTIVE: To analyze the clinical and laboratory features of Multiple Myeloma at presentation in a ...
Multiple myeloma (MM) is a relatively common haematological neoplasm composed of antibody-secreting ...
Blood Cells Mol Dis. 2000 Dec;26(6):634-45. Immunophenotypic aberrations, DNA content, and cell c...
textabstractMultiple Myeloma (MM) is a malignant plasma cell disorder accounting for 1% of all malig...
textabstractMultiple myeloma (MM) is a malignant plasma cell disorder that accounts for approximatel...
Background: Myeloma, the most common malignant disease of bone, is incurable and occurring with incr...
Multiple myeloma (also called Kahler\u27s disease [MM]) is a hematological malignancy of B lymphocyt...
The burden of Multiple myeloma varies worldwide, with the highest rates being reported in the most e...
Multiple Myeloma is a clonal plasma cell disorder that varies widely in its clinical course, ranging...
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malig...
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malig...
a heterogeneous entity with variable course. Plasma cells found in bone mar-row smears are character...
Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone...
Multiple myeloma (MM) is a B-cell neoplasm characterized by bone marrow infiltration with malignant ...
Multiple myeloma (MM) is a malignant plasma cell proliferation (chronic lymphoproliferative disorder...
OBJECTIVE: To analyze the clinical and laboratory features of Multiple Myeloma at presentation in a ...
Multiple myeloma (MM) is a relatively common haematological neoplasm composed of antibody-secreting ...
Blood Cells Mol Dis. 2000 Dec;26(6):634-45. Immunophenotypic aberrations, DNA content, and cell c...
textabstractMultiple Myeloma (MM) is a malignant plasma cell disorder accounting for 1% of all malig...
textabstractMultiple myeloma (MM) is a malignant plasma cell disorder that accounts for approximatel...
Background: Myeloma, the most common malignant disease of bone, is incurable and occurring with incr...
Multiple myeloma (also called Kahler\u27s disease [MM]) is a hematological malignancy of B lymphocyt...
The burden of Multiple myeloma varies worldwide, with the highest rates being reported in the most e...
Multiple Myeloma is a clonal plasma cell disorder that varies widely in its clinical course, ranging...
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malig...
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malig...
a heterogeneous entity with variable course. Plasma cells found in bone mar-row smears are character...
Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone...
Multiple myeloma (MM) is a B-cell neoplasm characterized by bone marrow infiltration with malignant ...
Multiple myeloma (MM) is a malignant plasma cell proliferation (chronic lymphoproliferative disorder...
OBJECTIVE: To analyze the clinical and laboratory features of Multiple Myeloma at presentation in a ...
Multiple myeloma (MM) is a relatively common haematological neoplasm composed of antibody-secreting ...
Blood Cells Mol Dis. 2000 Dec;26(6):634-45. Immunophenotypic aberrations, DNA content, and cell c...